April 2014
Volume 55, Issue 13
ARVO Annual Meeting Abstract  |   April 2014
Trends of Methicillin- Resistant Staphylococcus Aureus (MRSA) Keratitis in Western Pennsylvania: A 14- year study
Author Affiliations & Notes
  • Victoria Chang
    UPMC, Pittsburgh, FL
  • Regis P Kowalski
    UPMC, Pittsburgh, FL
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 2825. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Victoria Chang, Regis P Kowalski; Trends of Methicillin- Resistant Staphylococcus Aureus (MRSA) Keratitis in Western Pennsylvania: A 14- year study. Invest. Ophthalmol. Vis. Sci. 2014;55(13):2825.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: To report the incidence, current trends, and patterns of laboratory resistance to antimicrobial agents of culture- proven Methicillin (Oxacillin)- resistant S. aureus keratitis in Western Pennyslvania from 1998 to 2012

Methods: Setting: UPMC Eye Center, Pittsburgh, PA Study Population: During this 14- year period, 262 specimens of Staphylococcus aureus cultured from clinician confirmed keratitis cases in Western Pennsylvanian were included in this study. 37.8% (99 out of 262) of cases were found to be Methicillin (oxacillin)- resistant.. In vitro susceptibilities to selected antibiotics (Bacitracin, Vancomycin, Gentamycin, Ciprofloxacin, Cefazolin, Tobramycin, Sulfamethoxazole/trimethoprim, Polymyxin B) were determined by Kirby- Bauer disc diffusion method. The incidence of MRSA isolates and changes in the proportion of bacteria resistant to selected antibiotics were calculated and determined using the student t- test and cross- tabulation statistics with SPSS software.

Results: Between 1998 and 2012, there was no statistically significant change in laboratory resistance of staphylococcus aureus to methicillin (p>0.05, 0.23% in 1998 and 0.38% in 2012). 90% or greater susceptibility: Of specimens that were resistant to oxacillin, 100% and 96.9% were susceptible to Vancomycin and Sulfacetamide, respectively. 80% or greater susceptibility: 88.4% and 88.3% of MRSA specimens were susceptible to Bacitracin and Gentamycin, respectively. Of note, there were poor susceptibilities to the fourth- generation fluroquinolones: 24.4% susceptibility to Gatifloxacin and 30.9% susceptibility to Moxifloxacin. Only 19.2% of MRSA specimens tested were susceptible to Ciprofloxacin.

Conclusions: Our study demonstrates a stable incidence of MRSA isolates in a 14- year period in Western Pennsylvania. There were good susceptibilities to Vancomycin, Sulfacetamide, Bacitracin, and Gentamycin. There were poor susceptibilities to the fluoroquinolones.

Keywords: 720 Staphylococcus • 573 keratitis • 422 antibiotics/antifungals/antiparasitics  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.